Skip to content

Oxytocin and Resting State fMRI

Intranasal Oxytocin and Resting State fMRI in Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02689596
Enrollment
Unknown
Registered
2016-02-24
Start date
2014-10-31
Completion date
Unknown
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The goal of the study is to investigate the effects of intranasal oxytocin (OT) or placebo to resting state brain activity in healthy males.

Detailed description

Although several fMRI studies investigated the neural correlates of OT administration, only few have focused on the underlying modulatory effects of OT on baseline brain function. While functional MRI examines the neural activity during a certain task, it might be especially interesting to assess the main effect of OT on the basic activity of the human brain in rest. This resting state activity becomes typically evident in the default mode network (DMN), compromising midline structures such as medial frontal cortex, cingulate and precuneus, as well as specific resting state networks . In fact, a recent study succeeded in demonstrating a modulatory influence of OT. Recent studies were able to show an increased functional connectivity at rest of amygdala to the medial prefrontal cortex (PFC) in a small sample of 15 subjects. However, distinct subregions of the amygdala seem to be involved in different OT effects. To goal of the present study is to decipher the modulatory effects of OT to subregions of the amygdala in a larger sample using improved anatomical mapping of the seed regions and relate these alterations to individual traits of healthy volunteers. We expected to add evidence to the increase of amygdala - PFC connectivity under OT as well as detailed anatomical mapping of this networks.

Interventions

DRUGOxytocin
OTHERPlacebo

Sponsors

University Hospital Heidelberg
Lead SponsorOTHER

Study design

Primary purpose
BASIC_SCIENCE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Health

Exclusion criteria

* Chronic physical or mental illness, regular smoking or alcohol consumption and medication intake

Design outcomes

Primary

MeasureTime frame
Resting state brain activity using fMRI30min

Secondary

MeasureTime frame
Subject personality using questionnaires30min

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026